Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Mairs & Power Growth Fund underperformed in 2025 due to its strict avoidance of overvalued AI stocks and operational setbacks in Fiserv and UnitedHealth. The fund remains committed to valuation discipline, utilizing pullbacks to establish new positions in high-quality healthcare compounders Zoetis and Intuitive Surgical.
Full Quick Take
Mairs & Power Growth Fund underperformed in 2025 due to its strict avoidance of overvalued AI stocks and operational setbacks in Fiserv and UnitedHealth. The fund remains committed to valuation discipline, utilizing pullbacks to establish new positions in high-quality healthcare compounders Zoetis and Intuitive Surgical.
